最近在小分子抑制剂中取得的进步使得二化酶的小分子抑制剂取得了进展
Pengwei Liu1, Zhengyang Chen1, Yiting Guo1
1Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, PR China; Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou, 310018, PR China.
脱基酶 (DUBs) 是泛素-蛋白酶系统 (UPS) 的关键调节者. 针对DUBs显示出治疗癌症等疾病的前景,并且出现了PROTACs和DUBTACs等新方法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 蛋白质对于细胞平衡至关重要,其降解由基-蛋白酶体系统 (UPS) 和自控制.
- UPS功能障碍与主要的人类疾病有关,包括癌症,自身免疫和神经退行性疾病.
- 由于其在疾病发病过程中的作用,UPS是一个重要的治疗目标.
研究的目的:
- 审查最近在二维基因酶 (DUBs) 的进展.
- 为了突出DUB在UPS中的相关性.
- 探索DUB作为毒品目标的潜力.
主要方法:
- 文献综述,重点关注DUB及其在UPS中的作用.
- 对DUB抑制剂的临床前和临床研究的分析.
- 检查涉及DUBs的新兴治疗策略.
主要成果:
- 在UPS中,DUB是蛋白质稳定性和功能的关键调节器.
- 针对特定DUB的抑制剂 (例如USP1,USP7,USP14,USP30) 在癌症中显示出治疗潜力.
- DUB 抑制剂是新型治疗方式的组成部分,如 PROTAC 和 DUBTAC.
结论:
- DUBs代表了对各种疾病的有前途的治疗点.
- 针对性地抑制DUBs为药物开发提供了一个可行的策略.
- 像PROTAC和DUBTAC这样的新兴技术扩大了DUB调制的治疗效用.
更多相关视频
07:05Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay
Published on: September 27, 2024
09:45Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples
Published on: May 10, 2015
相关概念视频
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
